Tech Company Financing Transactions

Photys Therapeutics Funding Round

On 9/8/2022, Photys Therapeutics secured $75 million in Series A funding from MPM Capital, 8VC and Arkin Bio-Ventures.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Medical Devices & Instruments

Mailing Address

1 Bdwy. 14th floor
Cambridge, MA 02142
USA

Phone

Undisclosed

Website

www.photys.com

Email Address

Not Recorded

Overview

Photys Therapeutics' proprietary bifunctional small molecules platform unlocks fine-tuned control of protein post-translational modifications, going beyond degradation to restore protein function, repair signaling, and amplify endogenous disease-fighting mechanisms.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Brian Fenton

        

Chief Financial Officer

Jeff Capello

        

Chief Scientific Officer

Edward Holson

        

Browse more venture capital transactions:

Prev: 9/8/2022: Mysten Labs venture capital transaction
Next: 9/8/2022: Velaris venture capital transaction

Share this article

About Our Venture Capital Transactions Database

We document every notable VC transaction. All VC database entries reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary